ResearchNet - RechercheNet

• Search Again

• Back to Results

• Print Preview Opens in a new window

• Watch this Opportunity

• Notify a Colleague

Funding Opportunity Details

Funding Organization Canadian Institutes of Health Research Program Name Catalyst Grant
:

        Reimagine acute care **Sponsor(s)** The Institute of Circulatory and Respiratory Health

Program Launch Date 2026-03-24

Important Dates

| Competition | 202607CGC |
| --- | --- |
| Registration Deadline | 2026-06-03 |
| Application Deadline | 2026-07-23 |
| Anticipated Notice of Decision | 2027-02-03 |
| Funding Start Date | 2026-12-01 |

---

Notices

Tri-agency CV

This funding opportunity uses the tri-agency CV. This narrative-style CV is more flexible and allows applicants to best highlight their wide range of outputs and expertise. The tri-agency CV allows applicants to capture relevant information, describe their career trajectories in more detail, provide indicators of quality and impact, and provide context to their contributions in a narrative format to help peer reviewers assess their track record. More information on the new CV is available on the Tri-agency CV – frequently asked questions page.

As we gradually transition to the tri-agency CV, the system may continue to display references to the CCV. Please note that all participants must follow the tri-agency CV instructions as specified in the Funding Opportunity and complete and attach the tri-agency CV. For details on using the tri-agency CV on this funding opportunity, see the How to Apply section.

Webinar

CIHR will be hosting webinars to support participants with the requirements of this funding opportunity and to answer questions. To find out more information and to register, visit the Webinars page.

Partner Linkage

CIHR is providing a Partner Linkage Tool to facilitate collaboration that is intended to facilitate connections between researchers, knowledge users (e.g., practitioners, health-care providers/administrators, community-based organizations, persons with lived/living experience, policy/decision makers, Indigenous right-holders, etc.) or others that are interested in sharing information and/or forging collaborations in relation to acute care research.

This is not a mandatory tool. Information is provided on a volunteer basis and does not confer any advantages in the evaluation and funding of applications. The table will be updated weekly, until the application deadline. If you would like to use this tool, please complete a short survey. The information you provide will appear on a public CIHR web page. Please note that potential applicants are not required to use the linkage tool or contact those who have submitted their information.

Networking event

To facilitate collaborations between researchers from different research fields and disciplines, and to allow investigators to connect with communities, knowledge users and knowledge holders, CIHR is planning a networking event in Spring 2026. For more details about the networking event, visit: the ICRH website.

---

Table of Contents

• Description
• Objectives
• Eligibility
• Guidelines
• Review Process and Evaluation
• How to Apply
• Contact Information
• Sponsor Description
• Additional Information

---

Description

This Catalyst Funding Opportunity is part of CIHR-ICRH's Reimagine Acute Care initiative, focused on delivering better outcomes for all Canadians through research and evidence-informed decision-making in the research areas defined by ICRH's mandate: the heart; brain (stroke); lung; blood and blood vessels; sleep and critical care.

Conditions within ICRH's mandate represent a significant health challenge in Canada, causing approximately one-third of all deaths and accounting for four of the ten most expensive reasons for hospitalizations. Acute care in the hospital setting accounts for Canada's largest annual health expenditure. Many of these conditions, such as heart failure, asthma, and high blood pressure, are Ambulatory Care Sensitive Conditions where hospitalization may be avoided if managed with timely pre-acute care interventions. Late arrival to hospital care leads to complications, longer stays, and chronic disease development. Importantly, acute care access and outcomes are also largely influenced by social and economic factors. Therefore, certain groups like low income, rural and remote, racialized, immigrant and Indigenous populations experience additional barriers to optimal outcomes. Taken together, these observations highlight the need for a more integrated research approach to prevent or improve acute care outcomes.

Patient care in Canada is delivered through different phases and by different entities of the healthcare system. While acute care itself is often delivered by hospitals, pre-acute and post-acute care is delivered in different settings, such as primary care clinics or community-based centres. Although intended to prevent hospitalization or to enable effective discharge planning, our public healthcare system often leads to fragmentation of care resulting in the accumulation of disease burden as acute illness progresses to co- or multi-morbidity, costly readmissions and polypharmacy. Moreover, siloed research fields and disciplines hinder the integration of research across the care continuum. Addressing these challenges requires an integrated approach that links discovery directly to patient care through converging science initiatives.

Canada's health data ecosystem is undergoing a profound transformation. Building on national strengths in data science, artificial intelligence (AI) and digital health infrastructure, new technologies are enabling innovative ways to analyze and intervene in real-time on large volumes of heterogenous health information. In addition, novel technologies have the potential to accelerate research and help narrow the gap between discovery science and implementation. Seizing this transformational momentum requires expanding capacity and fostering collaboration in the research community within ICRH's mandate. Partnerships that leverage AI, computational science, and digital tools will help to catalyze the full potential of health data, drive innovation, advance science, and enable evidence-based decision making at the point of care.

To maximize impact and outcomes, ICRH will focus on improving the care continuum by connecting pre-acute, acute and post-acute care phases (see Research Areas section for a definition of different phases), using an interdisciplinary science approach to promote resilient health across the lifespan.

This funding opportunity will foster collaboration between researchers from different research fields, at different stages of their career, and promote research on different phases of the care continuum. It will also harness new technologies leading to more impactful research within ICRH's mandate area. This will be achieved through a coordinated approach utilizing diverse funding pools, each tailored to the collaboration-readiness of participating teams. Ultimately, the funding opportunity is intended to prepare the research community to become more competitive for cross-pillar, interdisciplinary networks, a critical aspect through which the Reimagine Acute Care initiative, will fund and foster projects within ICRH's mandate.

Strengthening interdisciplinary collaborations will enable Canadian researchers and the healthcare sector to improve evidence-based decision-making along the care continuum and lay the foundation to reduce the burden of disease, improve treatment outcomes and accelerate recovery.

Research Areas

A- Phases of Care

Projects must integrate a minimum of two (2) of the three (3) phases of the care continuum listed below. This requirement applies to all projects, irrespective of the funding pool chosen. The phases of the care continuum are:

1. Pre-acute care phase: The objective is to prevent hospitalization for at-risk patients. Areas of focus include but are not limited to pre-clinical disease markers, primary or secondary prevention, and access to care.
2. Acute care phase: The objective is to improve outcomes from medical and interventional procedures. Areas of focus include but are not limited to drug discovery, precision care, and medical and interventional outcomes.
3. Post-acute care phase: The objective is to enhance sustainable and effective health recovery. Areas of focus include but are not limited to multi-morbidity, recovery and prevention of rehospitalization. B- Eligible Research Fields

In addition to the phases of the care continuum listed above, projects must have a primary focus aligned with one or more of the following seven (7) Eligible research fields, as required by the selected funding pool:

1. Heart: Conditions of the heart, including myocardial dysfunction and heart failure, valvular, structural and congenital heart disease, congenital and acquired arrythmias, coronary disease and cardiac arrest.
2. Blood vessels: Conditions of the vascular system, including hypertension and atherosclerosis.
3. Brain (stroke): Limited to vascular aspects of brain health, including vascular, thrombotic and hemorrhagic stroke and vascular contribution to dementia.
4. Lung: Conditions of the lung, including chronic obstructive pulmonary disease, asthma and cystic fibrosis. This research field also includes the impact of inhaled toxic exposure to nicotine, vaping, inhalable drugs, air pollution and forest fires on the respiratory system, such as chronic bronchitis and emphysema, as well as aggravation of underlying chronic respiratory disease.
5. Sleep: Conditions of sleep, including sleep disordered breathing. This research field also includes the study of circadian rhythms.
6. Critical care: This research field includes intensive care and complications during intensive care, including sepsis, organ transplantation, surgery, pre- and post-operative care, anesthesia, trauma and life-support.
7. Blood: Conditions related to blood biology and function, including thrombosis, hemostasis, coagulation disorders, anemias, sickle cell disease and blood transfusion science. Conditions leading to complications in several of the above-mentioned Eligible research fields (ex: sepsis or sickle cell disease) are eligible under the cross-disease funding pools (A and C, see below), only if the research proposal addresses complications in a minimum of two (2) different Eligible research fields.

Note: The following research fields not in ICRH's primary mandate areas, are NOT relevant to this funding opportunity. These include projects where:

• The primary research focus is cancer.
• The primary research focus is infection and immunity, unless directly linked to sepsis in critical care.
• The primary research focus is diabetes.
• The primary research focus is obesity and metabolic disease. Funding Pools

For this funding opportunity, three (3) funding pools are available. Applicants must only select one. Should more be selected, only the first one will be considered.

1. Cross-disease funding pool Projects in this funding pool must focus on research on a minimum of two (2) Eligible research fields among the seven (7) listed above.
2. AI and computational science funding pool Projects in this funding pool must focus on the development, application and/or implementation of AI, computational or digital health tools to facilitate data use and analysis on one (1) of the Eligible research fields among the seven (7) listed above.
3. AI and computational science AND cross-disease funding pool Projects in this funding pool must focus on the development, application and/or implementation of AI, computational or digital health tools to facilitate data use and analysis on a minimum of two (2) Eligible research fields among the seven (7) listed above. All proposals, regardless of the funding pool selected, must address a minimum of two (2) of the three (3) Phases of Care.

Role and Contributions of Applicant Partners:

CIHR recognizes that a broad range of partners may be relevant to this opportunity and it is expected that applicant(s) describe the role of all applicant partners and how/if they will contribute to research and research related activities. Any consideration of risk and/or conflict of interest should also be explained, as appropriate.

Funds Available

CIHR and partner(s) financial contributions are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or decrease due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to grants received as a result of this funding opportunity.

The total amount available for this funding opportunity is $6,000,000.

• This amount may increase if additional funding partners participate.
• Of this $6,000,000:
  • $1,400,000 is available to fund approximately seven (7) grants relevant to the Cross-disease funding pool (funding pool A). The maximum amount per grant is $200,000 per year for up to one (1) year.
  • $1,400,000 is available to fund approximately seven (7) grants relevant to the AI and computational science funding pool (funding pool B). The maximum amount per grant is $200,000 per year for up to one (1) year.
  • $3,200,000 is available to fund approximately eight (8) grants relevant to the AI and computational science AND cross-disease funding pool (funding pool C). The maximum amount per grant is $400,000 per year for up to one (1) year. For more information on the appropriate use of funds, refer to Allowable Costs.

Top

---

Objectives

The objectives of this funding opportunity are to:

• Foster collaborations across Eligible research fields and/or disciplines and the phases of the care continuum to strengthen ICRH's research community, and prepare funded teams for interdisciplinary network funding opportunities, to ultimately improve healthcare outcomes.
• Enable researchers to generate preliminary data and/or AI-, computational or digital tools to catalyze future research and innovation, contributing to improving health care aligned with ICRH's mandate.
• Support early career researchers in initiating or participating in interdisciplinary research to build research capacity related to ICRH's mandate.

Top

---

Eligibility

Eligibility to Apply

For an application to be eligible, all the requirements stated below must be met:

1. The Nominated Principal Applicant (NPA) must be one of the following:
   1. an independent researcher or a knowledge user, affiliated with a Canadian postsecondary institution and/or its affiliated institutions (including hospitals, research institutes and other non-profit organizations with a mandate for health research and/or knowledge translation); or
   2. an individual affiliated with an Indigenous non-governmental organization in Canada with a research and/or knowledge translation mandate; or
   3. an Indigenous non-governmental organization in Canada with a research and/or knowledge translation mandate.
2. The NPA must have a substantive role in Canada for the duration of the requested grant term.
3. The Institution Paid receives and administers the funds on behalf of the NPA and therefore must be authorized to administer CIHR funds before the funds can be released.
4. For application to the Cross-disease funding pool (A), the application must include the NPA and at least one (1) Principal Applicant (PA). The NPA and the PA should have complementary expertise in the relevant Eligible research fields
5. For application to the AI and computational science funding pool (B), the application must include the NPA and at least one (1) Principal Applicant (PA). The NPA and the PA should have complementary expertise in the relevant Eligible research fields and AI or computational science, as defined in the funding pool.
6. For application to the AI and computational science AND cross-disease funding pool (C), the application must include the NPA and at least two (2) Principal Applicants (PAs). The NPA and the PAs should have complementary expertise in the Eligible research fields and AI or computational science, as defined in the funding pool.
7. The application must include an early career researcher identified as NPA or PA.
8. For any research applications involving First Nations, Inuit, and Métis populations, the research team must include:
9. A Principal Applicant (PA) or a Principal Knowledge User (independent researcher and/or knowledge user) who self-identifies as Indigenous (First Nations, Inuit or Métis) or provides evidence of having meaningful and culturally safe involvement with Indigenous Peoples, or both (see How to Apply for more details). An Indigenous Elder and/or an Indigenous Knowledge Holder as Co-Applicant or Collaborator.
10. The NPA and PAs must have successfully completed one of the sex- and gender-based analysis training modules available online through the CIHR Institute of Gender and Health and submit a Certificate of Completion (see How to Apply section). Please select and complete the training module most applicable to your research project. For additional information on sex, gender and health research, applicants are encouraged to review the " How to integrate sex and gender in research " section on the CIHR website.
11. An individual or an indigenous organization cannot submit more than one application as Nominated Principal Applicant. If the Nominated Principal Applicant submits more than one application, CIHR will automatically withdraw the last application(s) submitted based on the timestamp of submission. Note: Knowledge Holder/Keeper/Guardian: A Knowledge Holder (also known as a Knowledge Keeper or a Knowledge Guardian) is an Indigenous person, regardless of age, who possesses the Indigenous cultural knowledge necessary for the proposed research project or activities, as recognized, validated, and authenticated by the Indigenous community.

Top

---

Guidelines

General CIHR Policies

Before submitting an application to this funding opportunity, applicants should review the relevant policies and guidelines on the CIHR Funding Policies page, including the CIHR Application Administration Guide – Part 2 General Requirements for Grants and Awards Applications, to ensure understanding of their roles and responsibilities.

Research Security

The Policy on Sensitive Technology Research and Affiliations of Concern (STRAC Policy) is applicable to this funding opportunity. Consult the Tri-agency guidance on the STRAC Policy for more information.

Allowable Costs

Applicants are advised to consult the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Guide on Financial Administration (TAGFA) to determine if an expenditure is an appropriate use of grant funds.

Use of Personal Information

All information is shared in accordance with the Privacy Act. As per the Privacy Act, personal information means information about an identifiable individual that is recorded in any form.

• Personal information submitted during the application process, including but not limited to information provided through applicant CVs, the Tri-agency Self-identification Questionnaire and other application documents required by this funding opportunity, will be made available to select CIHR personnel with the appropriate training and security clearance and on a need-to-know basis, for the purposes of future program planning and design and evaluation and learning for organizational and program strengthening. In addition, CIHR may share de-identified, aggregated self-identification information with the sponsoring institutes and competition partners, for this purpose. For further information about the Self-identification Questionnaire and the use of personal information, see the Tri-agency Self-identification Questionnaire Frequently Asked Questions.
• The following information submitted to CIHR at the registration stage will be shared with the proposed institution paid for planning purposes: name of the NPA (and other applicants, if provided), application number, title of the proposal and requested budget.
• For this funding opportunity, some sections of the application containing information that directly or indirectly identifies the applicant(s), may be shared with some funding partner(s) and/or CIHR Institute staff, to assist with relevance review and funding decisions.
• Personal information, including related research security forms, collected as part of the implementation of the research security measures, may be shared with Canada's national security departments and agencies for the purpose of assessing risks to national security.
• Research reports (annual/progress/final) provided to CIHR may be shared with partners supporting the grant (See Conditions of Funding for report details). Conditions of Funding

In addition to the general conditions of funding governing CIHR grants following are the program specific conditions of funding applicable to this funding opportunity:

• Data related to First Nations, Inuit or Métis communities whose traditional and ancestral territories are in Canada must be managed in accordance with data management principles developed and approved by those communities, and on the basis of free, prior and informed consent. This includes, but is not limited to, considerations of Indigenous data sovereignty, as well as data collection, ownership, protection, use, and sharing.
• All information intended for public consumption, including for the purposes of informing and engaging partners (e.g., website content, information pamphlets, guidelines, promotional and event-related material, etc.), must be provided in both official languages (English and French), accessible to screen readers, and should be developed using plain language practices. See Allowable Costs for more details.
• CIHR is a signatory to the World Health Organization's Joint Statement on Public Disclosure of Results from Clinical Trials ("WHO Joint Statement") requiring all clinical trials to be registered and the results disclosed publicly in a timely manner. For more information, please consult the CIHR Policy Guide - Requirements for Registration and Disclosure of Results from Clinical Trials.
• Applicants are expected to adopt data management best practices to enable reproducible science and to enable successful sharing when possible (e.g., the FAIR principles – Findable, Accessible, Interoperable, Reusable), while respecting and promoting data sovereignty. Investigators must comply with all requirements of their chosen data sets/cohorts, including, but not limited to, policies governing Indigenous data. See Additional Information section for more details.
• CIHR reserves the right to terminate or suspend funding if there is a determination of unacceptable national security risk by the Government of Canada.
• Grantees must participate in a virtual kick-off meeting in Spring 2027, presenting the high-level aims of their projects, to create additional linkages and cross-fertilize ideas. This meeting will be organized by CIHR. At least one NPA or PA of each funded project must attend this event. The presence of the ECR identified as NPA or PA is strongly encouraged.
• The Nominated Principal Applicant (NPA) is responsible for the following reporting requirements:
  • A custom final report. This custom report will be made available to the NPA by email at least 2 months before the deadline for completion. This report will include providing a success story, written in layman's terms, which could be shared by CIHR for knowledge mobilization purposes.
  • An electronic Final Report. This online report will be made available to the NPA on ResearchNet at the beginning of the grant funding period and can be filled in as the research progresses.

Top

---

Review Process and Evaluation

Relevance Review Process

CIHR Institutes and partners will use the Summary of Research Proposal and the Relevance Review Form to perform a relevance review to identify applications that are in alignment with the objectives and the research areas of this funding opportunity.

In addition, applications must focus on the following requirements:

• Include a minimum of two (2) of the three (3) phases of care as defined in Research Areas.
• Align with the specific requirements of the funding pool selected. Applications that are not deemed relevant will be withdrawn from the competition.

Review Process

For information on the peer review process for this funding opportunity, see the Review guidelines – Priority-driven initiatives - CIHR.

For information on CIHR's peer review principles, see the Peer Review: Overview section of CIHR's website.

Peer review will be conducted in accordance with the San Francisco Declaration on Research Assessment (DORA).

Applications will be reviewed against selection criteria through asynchronous review, only applications with discrepant scores will be discussed by committee.

Evaluation Criteria

To support the strategic objectives of this funding opportunity, the following evaluation criteria will be used:

1. Research Approach
   1. Extent to which the project responds to the Objectives of the funding opportunity.
   2. Extent to which the research gap is well defined, and a clear rationale is provided for how the proposed work would meet this gap.
   3. Strength, feasibility and appropriateness of the proposed research design and methodology (including project timeline, access to and appropriateness of infrastructure or data to conduct the research and available personnel).
   4. For research projects involving First Nations, Inuit and Métis Peoples:
   5. The extent to which the proposed project recognizes the rights of Indigenous Peoples and Indigenous self-determination and self-governance, such as following the First Nations Principles of OCAP® i.e., Ownership, Control, Access and Possession), the CARE Principles for Indigenous Data Governance, and/or employing a distinctions-based (i.e., First Nations, Inuit, or Métis) approach, will be respected (see Additional Information).
2. Applicants
   1. Appropriateness of the applicants with respect to complementary and proven expertise, relative to career stage, phases of the care continuum (including pre-acute, acute and post-acute care) in the identified Eligible research fields, and with the proposed methodology/ies.
   2. Added value of the collaboration: Extent to which the proposal, the teams' planned activities (meetings, travel) and the governance appropriately support de novo collaboration or advancement of existing relationships, and contribute to mutual benefit, adoption and building of interdisciplinary/intersectoral expertise, as applicable.
   3. For research projects involving First Nations, Inuit and Métis Peoples:
   4. The extent to which the overall research team has the necessary knowledge, expertise and experience in Indigenous health research, and to which the research team has complementary expertise and synergistic potential to conduct Indigenous health research.
   5. Evidence of the capacity and experience of the research team to work in Indigenous communities in a meaningful and culturally safe way.
3. Impact of the research
   1. Potential for the proposed research, tools, or resulting data to advance existing knowledge or enhance current practices.
   2. Degree to which applicant partners contribute meaningfully to achieving the research objectives, where applicable.
   3. Appropriateness and suitability of strategies to anticipate and manage risks and challenges.
   4. Quality and appropriateness of the Data Management Plan (DMP).
   5. Extent to which the research outcomes could deliver tangible benefits to populations in Canada. For projects involving AI and large datasets, this includes the extent to which the research plan considers barriers experienced by specific populations and/or unintended outcomes of the research (e.g., responsible and ethical AI).
   6. Extent of the role(s) and contribution(s) of all applicant partner(s) in advancing research objectives (if applicable).
   7. Proactive and meaningful consideration of partnership risks, including the extent of real and/or perceived conflict of interest and appropriateness of its management and mitigation (if applicable). Funding Decision

Applications that receive a rating below 3.5 will not be funded. Applications relevant to each pool will be funded top down in order of ranking. Should there be residual funds in one or multiple funding pools, remaining fundable applications in the competition will be pooled together and funded in rank order until funds are fully allocated.

The names of successfully funded applicants will be published on the CIHR website.

Partner and Internal Collaborator Participation

The opportunity to add new partners and internal collaborators to this funding opportunity may arise after publication. These partners and internal collaborators may not be listed; however, the principles that govern relevance review, including consent to share information and funding decisions, will still apply.

Top

---

How to Apply

• The application process for this funding opportunity is comprised of two steps: Registration and Full Application
• To complete your Registration, follow the instructions in the Grants – Registration Guidelines, along with any additional instructions found below under "Specific Instructions".  Note that a Registration must be submitted to be eligible to submit a full application.
• To complete your Full Application, follow the "Specific Instructions" listed below, and where applicable, consult the Grants – Application Guidelines.
  • Note: This funding opportunity is using the tri-agency CV.
  • For applications written in French, additional pages will be permitted for the Research proposal and tri-agency CVs. See tasks for details.
• All participants listed, with the exception of Collaborators, are required to:
  • Have/obtain a CIHR PIN
  • Indigenous organizations applying as Nominated Principal Applicants for the first time must contact CIHR's Contact Centre for guidance in creating a ResearchNet account and registering for a CIHR PIN.
  • Complete the Tri-Agency Self-identification Questionnaire.
  • Keep your information up to date: Regularly review and update your My CIHR Profile, including confirming the correct Primary Affiliation is linked.
  • The Primary Affiliation field of the My CIHR Profile is important for various funding related activities, including eligibility assessments and Research Support Fund calculations (if applicable). Your My CIHR Profile can be accessed by clicking on your name in the top right-hand corner of the ResearchNet screen.  If your Primary Affiliation name is not available in the drop-down menu, contact the CIHR Contact Centre. Specific instructions to complete your ResearchNet application

Step 1 — Registration

Task: Identify Participants

• List the Nominated Principal Applicant (NPA) and the Principal Applicant(s) (PA). Consult the Eligibility section for the list of requirements.
• The Nominated Principal Applicant (NPA) must remain unchanged between the registration and full application phases of the competition. The Principal Applicants (PA) can be added or removed between the two stages.

• CV not required at this stage.
  Task: Enter Proposal Information

• This task collects information related to your research project. Complete the Overview, Details and Descriptors sections.

• A Research Proposal is not required at this stage.
  Task: Complete Summary of Research Proposal

• Summarize your proposal (1 page). The summary must include a description of how your proposal aligns with the objectives of this funding opportunity and the selected relevant funding pool.

  • Note that your summary cannot exceed one (1) page.
  • The summary will be used to find reviewers with the expertise required to assess the Full Application. Task: Apply to Priority Announcements/Funding Pools (Mandatory)

• Select the relevant funding pool as applicable, under the "Priority Announcement/Funding Pool Title" drop-down list:

  1. Cross-disease funding pool;
  2. AI and computational science funding pool;
  3. AI and computational science AND cross-disease funding pool

• Only one funding pool should be selected. If you select more than one, your application will only be considered for the first one identified.
  Task: Complete Peer Review Administration Information (Optional)

• This task collects information used for the purpose of peer review administration and aids CIHR in recruiting appropriate expertise.

• Suggest reviewers that have the expertise to review your application. You should not suggest reviewers in conflict of interest. Consult the Conflict of Interest and Confidentiality Agreement for Peer Reviewers and Peer Review Observers on the CIHR website for more information.

• CIHR reserves the right to make the final selection of reviewers.
  Task: Manage Access (optional)

• The Nominated Principal Applicant (NPA) can delegate access to a maximum of five individuals to support the completion of the application. Note: A delegate's access does not carry over from one stage of the competition to another (i.e., from the registration to the application stage). The NPA will need to delegate access at each stage of a competition. NPAs should revoke delegates' access prior to completing the Consent and Submit tasks if they do not want them to retain access to submitted applications via their Completed Activities tab. For more information, please see the Frequently Asked Questions (FAQ).
  Step 2 — Application

Task: Identify Participants

• List all participants. Consult the Eligibility section and ensure that all requirements are met. All participants (including partners and collaborators) must also be listed in the Participant Table under the task "Attach other Application Materials" (see below).
• The NPA and mandatory PAs (including the ECR) are required to submit a Tri-Agency CV, with a maximum of five (5) CVs in total to be submitted by Key Participants. The CVs should demonstrate the relevant expertise mentioned in the participant table. Any additional CVs submitted will be removed from the application.
  • As we gradually transition to the tri-agency CV, the system may continue to display references to the CCV. Please note that all participants must follow the tri-agency CV instructions as specified in the Funding Opportunity and complete and attach the tri-agency CV.
  • The maximum length of CVs is 5 pages in English and 6 pages in French. Any content in excess of the page limit set for the language will be removed without further notice to the CV owner(s) or the Nominated Principal Applicant.
• CVs must follow CIHR's formatting guidelines for attachments
  • ECRs must list any past and current research appointments in Section 1. Personal Statement of the Tri-Agency CV and clearly identify that they are an ECR and provide start and end dates for any medical/parental leaves.
  • Indigenous non-governmental organization applying as NPA must include, in their tri-agency CV, as part of Section 1. Personal statement, a description of the organization's mandate. This must include a description of how the organization meets the Eligibility requirement of being an Indigenous non-governmental organization with a research and/or knowledge translation mandate. As part of Section 2. Most significant contributions and experiences, the organization's relevant achievements must be emphasized, if applicable. In Section 3. Supervisory and Mentorship Activities, outline the organization's contributions to training and mentoring.
  • PWLLE/Community: Key Participants that fall in the PWLLE/community groups must include in their Tri-Agency CV a description of their relevant lived experiences in the context of the application.
  • For a Principal Applicant (PA) or a Principal Knowledge User (independent researcher and/or knowledge user) who self-identifies as Indigenous (First Nations, Inuit or Métis) or provides evidence of having meaningful and culturally safe involvement with Indigenous Peoples, or both must include in their CV a description of their relevant lived/living experiences in the context of the application.
  • Submit tri-agency CVs by uploading the completed documents in the " Attachment " tab and selecting " Curriculum Vitae " as the Document Type in the dropdown menu. CVs must be uploaded as PDFs and must be labelled as " Tri-Agency CV– Name (organization or individual, as applicable)". Consult the tri-agency CV instructions and the tri-agency CV – frequently asked questions for assistance with completing the tri-agency CV template.

Note: Elders and/or Indigenous Knowledge Holders identified as Key Participants may be named as Collaborators on your application, allowing them to participate without securing CIHR PINs. For these participants, please see instructions below under Task: Attach Other Application Materials for how to upload their tri-agency CV. Please note names of Collaborators do not appear in CIHR funding decision databases and documents.

Task: Enter Proposal Information

• The Research Proposal must address the objectives of the funding opportunity and the specific evaluation criteria.
• Research proposals written in French will be allowed to submit additional pages, in support of evidence demonstrating that French documents require approximately 20% more space than similar English documents. Therefore, to ensure an equitable amount of space is provided, the following page limits will apply:
  • Six (6) pages for Research Proposals written in English
  • Eight (8) pages for Research Proposals written in French Note: In order to ensure that all applicants have exactly the same amount of space, Research Proposal must adhere to the formatting requirements in the Acceptable Application Formats and PDF Attachments. Any additional pages over the above-mentioned limit will be removed with no further notification to the Nominated Principal Applicant.
• Attachment – Research Proposal Appendix" (optional)
  • References, charts, figures and tables can be uploaded under "Attachment – Research Proposal Appendix" (maximum five (5) pages). Note: Reviewers are under no obligation to read the Research Proposal Appendix documents. Therefore, the research proposal should be standalone and contain all the information required to support your research plan (i.e., it should contain a complete description of your project).

Task: Identify Sensitive Technology Research Areas

• If the research grant will aim to advance any of the listed Sensitive Technology Research Areas, the applicant must answer "Yes" to the screening question.
• All researchers with named roles in the research grant must review the List of Named Research Organizations, and are individually required to complete the Attestation form.
• The NPA must combine all attestation forms into one (1) PDF file and upload it under this task.
• Completed attestation forms will be neither accessible to, nor shared with, peer reviewers.
• CIHR will use this information to ensure applicants are compliant with the Government of Canada's policy on Sensitive Technology Research and Affiliations of Concern.

• For resources to assist in completing the Attestation form, please consult the Sensitive Technology Research and Affiliations of Concern, the Tri-agency guidance on the Policy on Sensitive Technology Research and Affiliations of Concern (STRAC Policy); and CIHR Research Security.
  Task: Complete Summary of Research Proposal

• Summarize your proposal (1 page). The summary must include a description of how your proposal aligns with the objectives of this funding opportunity and the selected relevant funding pool. Additionally, the Summary will be used to assess relevance in conjunction with the Relevance Form.

• The summary may be used to find reviewers with the expertise required to assess the application.
  Task: Enter Budget Information

• Provide a detailed budget justification in relation to planned activities and clearly justify all budget items (including cash and cash equivalent contributions, if relevant).

• Upload Release Time Allowance request under "Other Supporting Documents". For Release Time Allowance requests, you must include a letter from the recipient's organization certifying that the individual for whom the Release Time Allowance is requested:

  • Is a knowledge user on the grant whose primary responsibilities do not include an expectation to engage in research (i.e., as part of their regular employment);
  • Has their organization's approval for the research time on the project that would justify the allowance; and
  • Is engaged in the activities for which funds are being disbursed.

• For programs involving applicant partners: Include the costs, both cash and/or in-kind/cash-equivalent contributions, to be covered by the applicant partners. These must be listed in the "Other Funding" column of the "Financial Assistance Requested" section and must total the contributions listed in the Partner Details Forms. The budget requested from CIHR must be listed under the "CIHR" column.
  Task: Apply to Priority Announcements/Funding Pools (Mandatory)

• Select the relevant funding pool as applicable, under the "Priority Announcement/Funding Pool Title" drop-down list:

  1. Cross-disease funding pool;
  2. AI and computational science funding pool;
  3. AI and computational science AND cross-disease funding pool

• Only one funding pool must be selected. If you select more than one, your application will only be considered for the first one identified.

• Complete Relevance Form: The information in your Relevance Form must clearly describe (in one (1) half-page) how your proposal aligns with the objectives, the phases of care, the funding pool selected and the eligible research field(s) as described in the research area section. This information will be used to determine the relevance of your application to this funding opportunity.
  Task: Attach Other Application Materials

Note: Any pages over the page limits specified for attachments will result in the removal of additional pages with no further notification to the Nominated Principal Applicant.

• Other – attach the following under "Other":
  • Label as "Tri-Agency CV – Name" (Optional): Elders and/or Indigenous Knowledge Holders fulfilling a key participant role on the application but identified as Collaborators in ResearchNet for administrative purposes must have their tri-agency CV included in the application.
  • Label as "SGBA+ Certificate – Name" (mandatory for NPA and PAs): Certificate of Completion for the Sex- and gender-based analysis training modules (attach an unsecured version).
  • After completing the appropriate training module that applies to your research project, you will receive a certificate of completion that you will save and upload here. The training module should take approximately 40 minutes to complete.
  • Label as "Applicant Partner COI Document" (mandatory if applicable): Describe the role of all applicant partners, how/if they will contribute to research and research related activities, and any consideration of risk and/or conflict of interest as appropriate (Maximum 1-page)
  • Label as "Cultural Safety Form" (required if applicable): Applications involving First Nations, Inuit, and Métis populations must include at least one applicant who self-identifies as Indigenous (First Nations, Inuit, or Métis) or provides evidence of having meaningful and culturally safe involvement with Indigenous Peoples, or both. Complete and submit the Indigenous Health Research Cultural Safety Form.
  • Label as Data Management Plan (mandatory - maximum two (2) pages):
  • The Data Management Plan (DMP) should describe how the team will manage research data generated as part of its activities.
  • DMPs should describe what data are expected to be collected, created, linked to, acquired or recorded; how data will be documented, formatted, protected, and preserved; where data will be deposited, who will be responsible for managing the data, how data will be shared within and outside of the funded team; and any ethical, legal and commercial constraints the data are subject to (if applicable).
  • Applicants are encouraged to refer to CIHR's Data Management Plan Guidance for more information and/or the DMP Assistant to develop their DMPs. See Additional Information below for further details.
  • DMPs should be succinct and focused.
• Participant Table (mandatory) – Upload under "Participant Table":
  • This table will be used for Eligibility and peer review assessment.
  • In a table format with column headers matching the bolded titles below, provide the following information about all applicant team members (including Collaborators):
  • Name (Last Name, First Name / or name of Indigenous organization); List all participants on the grant, starting with those required in the Eligibility section;
  • Applicant type: (e.g. Early Career Researcher, Independent Researcher, etc.). For ECR(s), the year of the first independent appointment must be included for ECR eligibility verification. In addition, for ECRs:
    • If you have a gap in the chronology of your experience, indicate the length of time that needs to be considered in the ECR status calculation.
    • If you have a pending appointment, provide a letter from the dean of the faculty indicating the date your appointment is expected to take effect. The appointment must begin by the full application deadline.
  • Role of participants on the application (e.g., Nominated Principal Applicant, Principal Applicant, Principal Knowledge User, Co-Applicant, Knowledge User, Collaborator). In addition, identify the key applicants (maximum five (5)) who are providing CVs by adding "CV Attached" to their role;
  • Primary host institution/organization of each participant, where appropriate;
  • Expertise and Experience – In order to assess complementarity of disciplinary expertise across team members, include a brief description of what each participant brings to their role in the application. Applicants aligned with the required fields of research must be clearly identified;
  • Phase of the care continuum – Indicate the phase(s) of care with which the expertise aligns, if applicable.
• Publication list (optional) – Upload under "Publications":
  • List a maximum of five (5) publications from the last five years relevant to the proposal (maximum one (1) page).
• Letters of Support (optional – maximum of 5): Signed letters of support may include but are not limited to a description of specific cash or other in-kind contributions from Applicant Partner(s), as well as their role in the proposed project; or confirmation of pending faculty appointment from the Dean of the Faculty indicating the date the appointment is expected to take effect, if applicable. Please review the Writing Letters of Support document for guidance.
• Letters of Collaboration (optional – maximum of 5): Signed letters of collaboration may include but are not limited to letters specifying the nature of the collaboration from participants listed as Collaborators on the application.

Note: When completing the application, applicants must protect the privacy and confidentiality of all team members. How an individual self-identifies is personal and confidential information, which should not be disclosed without consent.
Task: Identify Application Partners (optional) – Upload Partner Information

• A "Partnership Details" form must be submitted for each partner providing cash and/or cash equivalent contributions.

• Upload a signed "Partner Letter" describing their role, activities, authorities, accountabilities and contributions (including intellectual, financial [cash or cash equivalent] and other resources).
  Task: Complete Peer Review Administration Information (Optional)

• Suggest reviewers that have the expertise to review your application. You should not suggest reviewers in conflict of interest. Consult the Conflict of Interest and Confidentiality Agreement for Peer Reviewers and Peer Review Observers on the CIHR website for more information. CIHR reserves the right to make the final selection of reviewers.
  Task: Manage Access (optional)

• The Nominated Principal Applicant (NPA) can delegate access to a maximum of five individuals to support the completion of the application. Note: A delegate's access does not carry over from one stage of the competition to another (i.e., from the registration to the application stage). The NPA will need to delegate access at each stage of a competition. NPAs should revoke delegates' access prior to completing the Consent and Submit tasks if they do not want them to retain access to submitted applications via their Completed Activities tab. For more information, please see the Frequently Asked Questions (FAQ).
  Task: Print Signature Page

• Signature Requirements:

  • Signature of the Nominated Principal Applicant is not required for applications submitted through ResearchNet.
  • Signatures must be included for all other applicants (except Collaborators), and individual(s) with signing authority from the Institution Paid.
  • Original signatures are not required. The scanned signed signature pages and the Routing Slip must be uploaded in the Print/Upload Signature Pages task in ResearchNet prior to submitting your application.

Top

---

Contact Information

For all inquiries, please contact:

CIHR Contact Centre
Telephone: 613-954-1968
Toll Free: 1-888-603-4178
Email: support-soutien@cihr-irsc.gc.ca

For service hours, please consult our CIHR Contact Centre page.

Top

---

Sponsor Description

Note: Additional partners/internal collaborators, including from industry and the private sector, may join this funding initiative over the coming year.

Internal Collaborators

Canadian Institutes of Health Research
At the Canadian Institutes of Health Research (CIHR), we know that research has the power to change lives. As Canada's health research investment agency, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.

CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH)
The Institute of Circulatory and Respiratory Health (ICRH) supports research into causes, mechanisms, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions associated with the heart, lung, brain (stroke), blood, blood vessels, critical care and sleep.

Top

---

Additional Information

The Nominated Principal Applicant and team members are strongly encouraged to any complete any of the applicable training modules of CIHR, including, but not limited the CIHR research data training module, before crafting their proposal.

Data Management Plans

A Data Management Plan (DMP) is a formal document that details the strategies and tools to effectively manage data both during the research project and after its completion. DMPs contribute to:

• Efficiency – identify strategies and potential challenges in advance; develop sound data practices for the research team; prepare data for effective use during the project.
• Research Quality – ensure reliability and accuracy of data through careful documentation of data collection, handling and stewardship practices.
• Reusability and Impact – improve discoverability, accessibility, and reusability of data by planning for sharing in a repository; and increase the potential impact of research. For more information on research data management and DMPs, visit the Frequently Asked Questions of the Tri-Agency Research Data Management Policy, and the Training Resources page of the Digital Research Alliance of Canada.

The DMP Assistant is a national, online, bilingual data management planning tool developed by the Digital Research Alliance of Canada to assist researchers in preparing DMPs. This tool is freely available to all researchers and develops a DMP through a series of key data management questions, supported by best-practice guidance and examples.

If using DMP Assistant to create the DMPs, when asked to choose a template, applicants should select the "Alliance Simplified (Funding Application Stage)" template. Questions about using the DMP Assistant should be directed to DMP Assistant Support.

Top

• Search Again

• Back to Results

• Print Preview Opens in a new window

• Watch this Opportunity

• Notify a Colleague
  Date Modified:

20260226.1